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Vascular calcification is an important determinant of cardiovascular mortality. The 
mechanisms responsible for vascular calcification are controversial. It has been suggested that 
the bone marrow derived osteo-progenitor population may contribute to the development of 
arterial mineralization. Osteocalcin expressing mononuclear cells (OCN+ MNCs) have 
recently been demonstrated within the circulation of adults and shown to have ability to carry 
out mineralization both in vitro and within mice. The aim of this study was to assess the 
association of vascular calcification with circulating bone marrow derived osteo-progenitors 
and stem cell mobilizing cytokines in two mice models and a human patient cohort. 
 
We investigated a number of mice models including one dependent on calcitriol injection in 
osteoprotegerin deficient (OPG-/-) mice (n=12). The severity of aortic calcification in the 
aortas of 12 month old male (n=10) and female mice (n=10) was evaluated using alizarin red 
staining and a bioassay. Tail bleeds (n=160) were analyzed for OCN+ MNCs using flow 
cytometry. We also estimated the percentage of circulating OCN+ MNCs using flow 
cytometry in patients (n=23) suffering from peripheral artery diseases. Infra renal aortic 
calcification volume was measured in patients by computed tomography. Stem cell 
mobilizing cytokines such as stromal cell derived factor (SDF-1α), granulocyte colony 
stimulating factor (G-CSF) and stem cell factor (SCF) were investigated in patient plasma 
samples. A three way correlation was assessed for infra renal calcification volumes, 
circulating OCN + MNCs and these cytokines. 
 
Comparative studies showed that the percentage of circulating OCN+ MNCs was 
significantly more in mice with aortic calcification than control animals. The severity of aortic 
calcification was correlated to the number of circulating OCN+ MNCs (r=0.525 for male and 
0.563 for female mice). When aortic calcification was accelerated using calcitriol similar 
associations were demonstrated in younger mice (r= 0.641 in OPG-/- with calcitriol vs. r=0.525 
in older OPG-/-  without calcitriol) In human study, Patients with more severe aortic 
calcification (calcification volume ≥ median) had a greater percentage of circulating OCN+ 
MNCs (median 4.07 %, IQR 3.76-4.39, n=12) than those with less severe aortic calcification 
(median 3.10 %, IQR 2.32-3.60, n=11, p=0.05). The OCN+ MNC percentage was moderately 
correlated (r=0.475, p=0.22) with aortic calcification volumes. Similarly, plasma SDF-1α, G-
CSF and SCF concentrations were also observed to be significantly associated with the OCN+ 
MNC percentage (0.597, p=0.03; 0.654, p=0.001; 0.654, p=0.003 respectively) and 
calcification volumes (0.480, p=0.01; 0.522, p=0.001; 0.480, p=0.01 respectively) 
 
This study demonstrates, for the first time, that circulating bone marrow derived osteo-
progenitors can be robustly quantified in murine as well as patient cohort with varied degree 
of aortic calcification. OCN+ MNC were associated with the severity of aortic calcification. 
Overall our findings have implications for bone marrow based cellular therapies being 
developed. 
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